The occuloalbinism 2 (OCA2) gene, localized at 15q11, encodes a melanosomal transmembrane protein that is involved in the most common form of human occulo-cutaneous albinism, a human genetic disorder characterized by fair pigmentation and susceptibility to skin cancer. We wondered whether allele variations at this locus could influence susceptibility to malignant melanoma (MM). In all, 10 intragenic single-nucleotide polymorphisms (SNPs) were genotyped in 113 patients with melanomas and in 105 Caucasian control subjects with no personal or family history of skin cancer. By comparing allelic distribution between cases and controls, we show that MM and OCA2 are associated (p value ¼ 0.030 after correction for multiple testing). Then, a recently developed strategy, the 'combination test' enabled us to show that a combination formed by two SNPs was most strongly associated to MM, suggesting a possible interaction between intragenic SNPs. In addition, the role of OCA2 on MM risk was also detected using a logistic model taking into account the presence of variants of the melanocortin 1 receptor gene (MC1R, a key pigmentation gene) and all pigmentation characteristics as melanoma risk factors. Our data demonstrate that a second pigmentation gene, in addition to MC1R, is involved in genetic susceptibility to melanoma.
Introduction
Malignant melanoma (MM) is increasing in most Caucasian populations, with an incidence doubling every 10 years. 1 Approximately 10% of MM cases are familial, and germline mutations affecting two highly penetrant melanoma-predisposing genes, CDKN2A and Cdk4, have been identified. 2 -5 In addition, loss-of-function variants of the human melanocortin-1 receptor gene, MC1R, which plays a crucial role in pigmentation, have been shown to be important risk factors determining sporadic melanoma. 6 -8 Tyrosinase-positive oculocutaneous albinism (OCA, type II), the most prevalent type of albinism, 9 is an inherited autosomal recessive disorder due to germline mutations of the P gene (occuloalbinism 2 (OCA2)). OCA2 maps to chromosome 15q11.2 -12, consists of 25 exons, encoding a vacuolar 838-amino-acid protein 10, 11 that is the human homologue of the mouse pink-eyed dilution locus, p.
12,13
The product of the mammalian p gene is an integral membrane protein with a predicted 12-transmembrane domain structure, resembling a channel or transporter, 12 -15 and recessive mutations at the mouse p locus result in diminished coat and ocular pigmentation. The p locus plays an important role in melanosome biogenesis, and controls the eumelanin content in melanocytes 16 -20 in part via the processing and trafficking of tyrosinase -the rate-limiting enzyme in melanin synthesis. 21, 22 Albino patients are highly predisposed to sun-induced skin cancers including mainly non-melanoma skin cancers (NMSC), but also less frequently melanoma. The OCA2 gene is highly polymorphic, 23 and is suspected of playing an important role in human pigmentation. 24, 25 Accordingly, it has recently been shown that two OCA2 nonsynonymous variants are partly responsible for determining normal phenotypic variations in human eye colour, suggesting that variations of this gene may constitute an inherited biomarker of the skin cancer risk. 26 Therefore, in this study, we investigated the effect of germline allele variations at the OCA2 gene on susceptibility to MM. In addition, we also studied whether the effect of OCA2 on MM persists after stratification for pigmentation characteristics.
Materials and methods

Study population
A total of 120 patients with MM and 125 controls were recruited. In all, 29% of the MM patients were incident cases, and 71% were prevalent cases. The median time between the diagnosis of melanoma and blood sampling was 44.6 months. All participants were French Caucasians and had been recruited by the Dermatology Departments of four hospitals in Paris (France): the Bichat ClaudeBernard, Percy, Ambroise Paré and Saint-Louis Hospitals. The study population consisted of patients between 20 and 80 years of age with histologically proved MM. Seven patients displaying CDKN2A germline mutations were excluded.
A previously described French Caucasian control group, 14 with no personal or family history of skin cancer, was used for comparison of OCA2 allele frequencies. The control subjects, between 20 and 80 years of age, were recruited from the same hospitals as the MM cases to provide a typical sample of people living in the same demographic area. The Medical Ethics Committee (CCPPRB) approved the study protocol. Informed consent was obtained from all the patients and control subjects enrolled in the study.
Collecting data about risk factors for MM The participants underwent a standardized personal interview conducted by a dermatologist, and a total skin examination was performed to collect data, which was reported using a pre-printed examination report form.
Information was recorded about skin colour (classified as dark, medium, or fair), eye colour (classified as dark (brown or black) or light (blue, green/hazel, or grey)) and original (before greying) hair colour (classified using five categories: red, blond, light-or dark-brown, and black). The nevus body count (o or X50 nevi), the presence or absence of atypical mole syndrome (50 or more nevi, with at least 3 of them being clinically atypical, that is, 6 mm or more in size, and characterized by variable pigmentation, indistinct borders and irregular outline), 27 and the presence or absence of solar lentigines were also assessed by means of physical examination by a dermatologist. Skin types were assessed according to the Fitzpatrick classification as follows: always burns never tans (skin type I); always burns then tans (skin type II); always tans sometimes burns (skin type III); and always tans never burns (skin type IV). The control subjects underwent the same interview and examination. Genomic DNA was isolated from peripheral blood leukocytes of all the participants by routine methods.
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OCA2 single-nucleotide polymorphism (SNP) genotyping A total of 10 SNPs on the OCA2 gene were studied (Table 1) . Eight SNPs were chosen from the NCBI SNP database (http://www.ncbi.nlm.nih.gov/SNP/index.html) or The International Albinism Database (http://www.cbc.umn.edu/ tad/), and two (IVS13 þ 112 A/G and IVS13 þ 180 C/T) were identified by sequencing. Five SNPs (two exonic and three intronic) were genotyped by sequencing the whole of exon 13 of OCA2 ( Table 1 ). The other five SNPs were genotyped using the Snap Shot procedure, according to the manufacturer's instructions (Perkin-Elmer), by using a specific primer extension reaction (Tables 1 and 2 ). All profiles corresponding to the different genotypes were confirmed by direct sequencing of the PCR products.
Detection of MC1R functional variants
The MC1R coding sequence was amplified by PCR with two overlapping couples of primers, as described previously. 29 Sequence analysis was performed on an ABI-Prism 3100 automated DNA sequencer using 10 ng of PCR purified products and Big-Dye Terminator Cycle Sequencing kits (Perkin-Elmer), according to the manufacturer's instructions. For genetic analysis, only the MC1R polymorphisms retained were those (a) previously shown to be loss-of-function variants by functional studies 30 -35 and/or (b) associated with MM risk. 6, 7, 35 Statistical analyses Association between MM and pigmentation characteristics The association between MM and each pigmentation characteristic was tested using a w 2 test.
Genotype data
SNPs for which the minor allele was rare (fewer than five individuals heterozygous or homozygous for the minor allele) were not included. The degree of linkage disequilibrium (LD) between the different SNPs was calculated using the correlation coefficient as described previously.
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Test of the association between OCA2 and MM Allelic distribution between cases and controls was first compared for each individual SNP and a permutation procedure was used to correct for multiple testing. The same analysis was then performed for genotypic distribution.
The association was further examined with a recently developed method, the 'combination test', 37 that consists in comparing the distribution of the genotypes resulting from all possible combinations formed by a variable number of SNPs in the MM cases and controls. With seven studied SNPs, seven tests are performed for single SNPs, 21 (7!/5!2!) for combinations of two SNPs, 35 for combinations of three SNPs and so on, giving a total of 127 performed tests for all possible combinations of these SNPs. All these tests are in fact interdependent, because many of the tests are nested in others, and because the SNPs are in LD. To allow for this dependency when correcting for multiple testing, a permutation procedure was used to calculate the level of significance of the test. Furthermore, asymptotic conditions did not apply for each individual test. This permutation procedure was therefore also useful to estimate the level of significance of each test, as it provides an empirical distribution for each test. A simulation study 37 has shown for a quantitative trait locus that the 'combination test' has in complex situations of gene involvement a better power than the two commonly used tests, the association test of each single SNP and the association test of the genotypes formed by all SNPs. Using the 'combination test' enabled us to extract all the combinations that were significantly associated with MM at 5%-Type 1 error. These combinations are helpful for determining disease-risk and protective genotypes. As many nested combinations could be associated with MM, we implemented a strategy to extract from these 
Results
Composition of the study population and pigmentation characteristics
The final group analysed comprised 218 subjects: 113 patients with MM and 105 control subjects. The strongest clinical risk factors identified for MM were a mole count greater than 50 (Po0.0001), the presence of an atypical mole syndrome (P ¼ 0.0002), fair skin (P ¼ 0.0001), and dorsal lentigines (Po0.0001). Less powerful predictors for MM were fair hair and eye colours (respective P-values of 0.003 and 0.002).
Genetic analysis
A total of 10 SNPs were genotyped (see Materials and methods and Table 1 ). Three SNPs were excluded from the statistical analysis, because one of the two alleles was absent (G720G, L440F), or rare (I722T, which was present in one patient and two control subjects). The analysis was therefore performed using seven SNPs (Table 3 ). In addition, a previously reported OCA type 2 pathogenic mutation, V443I, located in exon 13 9 was found in two of the patients but in none of the controls. The LD study (Table 4) showed that SNP 2 was in strong positive LD with SNP 3, SNP 5 and in strong negative LD with SNP 6, and that SNP 3 was in almost complete LD with SNP 6 and in strong LD with SNP 7. It should be noted that the correlation between the alleles of SNP 3 and SNP 6 in the case sample is weaker (r ¼ 0.89) than in the control sample. Then, the information provided by these two SNPs is not redundant and both SNPs have therefore been kept for the analysis.
Association between OCA2 genotype and MM risk
Allelic distributions between MM patients and control subjects were significantly different for three different SNPs, SNP 2, 3 and 5 (respective nominal P-values: 0.006, 0.009 and 0.009, see Table 3 ). These associations were still significant after correction for multiple testing.
In contrast, when genotypic distributions were compared for each individual SNP, none of the association tests achieved significance. This could be explained by a loss of power, as three genotypic categories are considered for each SNP instead of two allelic categories.
However, using the 'combination test', which also compares genotypic distribution between patients and controls, we concluded the association between OCA2 and MM (P ¼ 0.03 after correction for multiple testing). Indeed, several combinations of SNPs were significantly associated with MM, but none with a single SNP. Among the associated subsets of SNPs, the one retained by the 'combination test' was formed by SNP 3 and 7 (nominal P-value: 0.001). When exploring risks associated with the genotypes formed by the alleles of these two SNPs, we found different risks for several genotypes. Notably, there was a major protective genotype, double homozygous for the minor allele of SNP 3 and the major allele of SNP 7, that was present in 11% of control subjects, but not in any MM patients (Table 5) .
Effect of OCA2 on pigmentation characteristics
After correction for multiple testing, we found that the only pigmentary characteristic associated with OCA2 was eye colour (association of the minor allele of SNP 5 with dark eye colour, P ¼ 0.007). This result was confirmed using the combination test, the subset of SNPs that was retained including only the SNP 5.
Persistence of MM risk after stratification for pigmentation characteristics By applying the 'combination test' to the dark eyes and the light eyes groups, we found that the association of OCA2 with MM persisted after stratification for eye colour (P ¼ 0.05 for dark eyes and P ¼ 0.01 for light eyes). This suggests that although eye color is associated with the OCA2 genotype, it does not account for the MM susceptibility due to OCA2. Values of the correlation coefficient were calculated as described in the Materials and methods section. Multiple regression of the OCA2 genotype, MC1R variant and pigmentation characteristics MC1R functional variants, that are considered to be an important melanoma risk factor, were present in 65% of the patients and 30% of the control subjects (Po0.0001). Interestingly, in a multiple logistic regression analysis on MM considering the presence or the absence of MC1R variants, OCA2 genotypes 12-22 and 22-11 versus all other genotypes and all pigmentation characteristics as dependent variables, removing OCA2 always significantly decreased the model fit. In fact, the OCA2 genotype appeared as the MM risk factor producing the second greatest decrease in the model fit, after a high nevus count (Table 6 ). This confirms that even when clinical MM risk factors have been taken into account, OCA2 still has a residual effect on MM risk.
Discussion
Previous studies have shown that OCA2, a gene involved in the most frequent form of albinism, is highly polymorphic in Caucasian and African populations of different geographic origins. 23, 38, 39 In this study, using both conventional statistical methods and the 'combination test', a recently developed test that takes genetic information from numerous genetic markers into account, we have shown the influence of OCA2 genotype on melanoma susceptibility independently of its role on eye colour in a French population.
The combination of SNPs most strongly associated to MM was formed by two SNPs, SNP 3 and 7. Two nonmutually exclusive hypotheses may explain why a combination of two SNPs was more associated to MM than individual SNPs. Firstly, one or several functional variants may be in LD with haplotypes determined by different combinations of SNP 3 and 7. Secondly, several variants may interact to produce a detectable effect on MM risk. It has already been noticed that the individual effect of a variant can be too weak to be detected individually and that interactions of multiple SNPs within the same gene can affect a phenotype. 40 Therefore, some OCA2 variants and/or their epistatic interaction could possibly produce hypomorphic alleles diminishing eumelanin synthesis. It should also be noted that a pathogenic mutation of OCA2 previously characterized in OCA type-2 patients, V443I, was identified in two patients, but in none of the control subjects. As noted previously, 41 a large number of OCA2 polymorphisms have been reported and examination of a wider range of common alleles together with a comprehensive search for variation within the OCA2 gene is needed to fully understand the genetic relationship between MM and the OCA2 locus. An association between OCA2 and pigmentation characteristics has recently been suggested. 24, 26, 41, 42 The association of SNP 5 with eye colour has been previously shown in populations of different geographic origins. 41, 43 The replication of this result in a French population enhanced the role of OCA2 in eye colour. However, contrary to these studies, we observed no association of SNP 1 with eye colour, a result that may be either due to the different geographic origin of our population or due to the different classification used for eye colour in our study.
In addition, our results show that OCA2-related MM risk persisted after stratification for eye colour. This result is not surprising as different variants seems to be involved in MM and eye colour (ie combination of SNP 3 and 7 for melanoma and SNP 5 for eye colour). Furthermore, OCA2 genotypes significantly increase the fit of a logistic regression on MM after taking into account all pigmentation characteristics and an important susceptibility melanoma gene, MC1R, enhancing this result.
The physiopathological basis of the role of OCA2 in human pigmentation and melanoma susceptibility can be extrapolated from animal models. 17 The eumelanin content, the proliferation, and the differentiation of melanoblasts and melanocytes are all greatly reduced p mutant mice. 17 It therefore seems quite reasonable to assume that the quantity and/or quality of melanin, that determines part of the risk of skin cancer, is strongly influenced by the OCA2 protein. In fact, a decrease of eumelanin in OCA2-variant melanocytes could contribute to mutagenesis and confer susceptibility to MM and nonmelanoma skin cancer by enhancing toxicity of free radicals following ultraviolet exposure. In addition, OCA2 could also increase melanoma susceptibility via mechanisms that are in part independent of the melanogenesis process. This is supported by the fact that the pink-eyed dilution protein increases cellular sensitivity to arsenicals and other metalloids by modulating the intracellular glutathione metabolism that is involved in the detoxification of reactive free radicals of oxygen. 11 Loss-of-function OCA2 mutant melanocytes The P-value corresponds to the removal of one risk factor.
could become more resistant to photo-induced stress and perhaps go on to be transformed more easily into MM cells. In summary, our findings show that the OCA2 genotype influences melanoma risk, even after pigmentation characteristics are taken into account, and that the risk is likely the result of several OCA2 variants, possibly interacting.
